Monday, 9 February 2015


Moody's Microblog Daily Digest 150207 - yesterday's tweets as a single page

Ideology Matters: Parsing Recent Changes in China’s Intellectual Landscape - important analysis of Xi's recent moves

Climate change marchers told to hire private security firm - oh look: now only the rich are allowed to hold marches

this - also yet another example of the #privatisation of #policing in UK, hurtling towards US-style abuses

Aaron Swartz stood up for freedom and fairness – & was hounded to his death - "determined to make an example of him"

Public draft of the #opendata maturity model - "assess how effective at publishing and consuming open data."

#TTIP Updates - The Glyn Moody blogs - includes all 50 columns. maybe that's it: no more now...

.@guardian: Britain isn’t buying everything in #TTIP - #ISDS: "means of putting frighteners on elected governments"

.@guardian:"#ISDS has made the [#TTIP] deal politically toxic on this side of the Atlantic" -

"Labour MEPs say [TTIP] comes up often when they are canvassing" - well done, people: word is getting out

Bitter economic winds hasten oil industry’s retreat from the North Sea - end of an era; now we need #disinvestment

"increasing pressure on pension funds to disinvest from oil and coal - they represent a “carbon bubble” of overvalued & endangered assets."

Church of England may sell £3m stake in mining firm over fears for gorilla haven - kudos #Virunga #SoCo

Mercury levels in yellowfin tuna have been increasing steadily since 1998 - our stupidity will make us stupid

“Cyberspace” must die. Here’s why - I quite agree; also, drop that "cyber" prefix....

So where’s the ‘moral hazard’ in restructuring Greek debt? - not where they would have us believe

#TTIP’s impact - excellent, detailed analysis of overstatement of benefits, understatment of risks; fully referenced

Self-organised European Citizens’ Initiative against #TTIP & #CETA - now at incredible 1,407,782: have you signed?

MJA: What doctors should know about #TPP - more people will die as a result of its longer pharma patent monopolies

No comments:

Post a comment